RESOURCE
|
January 20, 2020

Role of Alcohol Drinking in Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis

Research
International Journal of Molecular Sciences
SUMMARY

This paper explores the dual effects of alcohol on neurodegenerative diseases such as Alzheimer’s (AD), Parkinson’s (PD), and Amyotrophic Lateral Sclerosis (ALS). Light to moderate alcohol intake may reduce the risk of AD by protecting neurons against certain toxic proteins, but excessive alcohol exacerbates brain damage through oxidative stress and inflammation. For PD, evidence is mixed, with some studies suggesting that beer may reduce risk, while heavy drinking harms dopamine pathways. ALS shows inconsistent findings, with limited data suggesting possible protective effects of moderate consumption. Overall, chronic heavy drinking is harmful, while low consumption might confer some benefits under specific conditions.

RECOMMENDATION

If you consume alcohol, moderation is key. Limit intake to light-to-moderate levels (e.g., a glass of wine or beer occasionally) to potentially benefit brain health while avoiding risks tied to heavy drinking. However, given mixed evidence, these benefits should not be a reason to start drinking if you abstain. Focus on other proven brain-healthy habits like a balanced diet, regular exercise, and cognitive stimulation. Consult a healthcare professional for personalized advice.

TAGS
alcohol; Alzheimer’s disease; Parkinson’s disease; amyotrophic lateral sclerosis; neurodegenerative diseases; neuroprotection; oxidative stress; inflammation; dopamine; beta-amyloid
DEEP DIVE